ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 26 filers reported holding ARCA BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 12.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,708 | -31.6% | 10,800 | -31.0% | 0.00% | – |
| Q2 2023 | $31,751 | -61.3% | 15,641 | -62.0% | 0.00% | – |
| Q1 2023 | $82,010 | +63.3% | 41,211 | +93.7% | 0.00% | – |
| Q4 2022 | $50,223 | -48.2% | 21,281 | -54.5% | 0.00% | – |
| Q3 2022 | $97,000 | -58.7% | 46,810 | -50.3% | 0.00% | – |
| Q2 2022 | $235,000 | -1.3% | 94,133 | -8.6% | 0.00% | – |
| Q1 2022 | $238,000 | +23.3% | 102,937 | +15.1% | 0.00% | – |
| Q4 2021 | $193,000 | -14.2% | 89,467 | +18.0% | 0.00% | – |
| Q3 2021 | $225,000 | -16.4% | 75,807 | -1.1% | 0.00% | – |
| Q2 2021 | $269,000 | +2.7% | 76,686 | +6.8% | 0.00% | – |
| Q1 2021 | $262,000 | +482.2% | 71,798 | +605.8% | 0.00% | – |
| Q3 2020 | $45,000 | – | 10,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 95,715 | $661,000 | 0.29% |
| Quantamental Technologies LLC | 5,148 | $38,000 | 0.01% |
| Tekla Capital Management LLC | 36,068 | $264,000 | 0.01% |
| Hudson Bay Capital Management LP | 35,870 | $263,000 | 0.01% |
| Renaissance Technologies | 80,485 | $589,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 17,333 | $128,000 | 0.00% |
| Advisor Group, Inc. | 55 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 40 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 111 | $1,000 | 0.00% |